Health
This is to provide Latest HealthNews around the globe
-
Retatrutide: The newest weight loss drug showing promise | Health
SHREVEPORT, La. – A new drug developed by Eli Lily works in a unique way compared to treatments already on the market, like Ozempic and Mounjaro. It’s called retatrutide, and what makes retatrutide different is that it targets not just one or two, but three hormone receptors in the pancreas: GLP-1, GIP, and glucagon. These are all naturally occurring hormones…
Read More » -
Majority of Americans think alcohol bad for health: poll
Credit: CC0 Public Domain A narrow majority of Americans now believe even moderate consumption of alcohol negatively affects health, as US drinking levels continue to decline, according to a recent survey. Pollster Gallup found the number of Americans who said they drink alcohol to be at an all-time low since the poll was first conducted in 1939—a few years after…
Read More » -
AI voice test could help spot dangerous throat lesions before symptoms appear
In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: By measuring subtle changes in voice quality, AI could help doctors detect dangerous vocal fold lesions before symptoms worsen. Study: Voice as a biomarker: exploratory analysis for benign and malignant vocal fold lesions. Image Credit: 3dMediSphere / Shutterstock…
Read More » -
Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs
Texas Attorney General Ken Paxton filed a lawsuit against Eli Lilly, accusing the drug maker of bribing doctors to prescribe their medications. Paxton said the quid pro quo arrangements tainted millions of dollars of claims to Texas Medicaid. The lawsuit accuses Eli Lilly of providing doctors offices with free nurses to conduct patient-care services. That work is largely unprofitable and…
Read More » -
Akron Children’s to provide health services in Marietta, Belpre schools | News, Sports, Jobs
(Photo Illustration – MetroCreativeConnection) MARIETTA — As children head back to class in the Marietta and Belpre City school districts, they will have access to a variety of pediatric-focused health services offered in their school buildings through a new partnership between the districts and Akron Children’s. Akron Children’s School-Based Health Center (SBHC) is one of the services offered through new…
Read More » -
Free naloxone dispensers proliferate, but not in Gig Harbor – Gig Harbor Now
Community Health & Wellness Finding naloxone, a medication that can reverse an opioid overdose, has become much easier since pharmacies and retailers throughout Washington began selling it over the counter two years ago. For Gig Harbor and the majority of communities in South Kitsap, businesses offer one of the few places where the life-saving medication is publicly available. Low-barrier options,…
Read More » -
High metabolic syndrome severity linked to development of CKD
High metabolic syndrome (MetS) severity, expressed by the continuous metabolic syndrome severity score (cMetS-S), is associated with development of chronic kidney disease (CKD), according to a study recently published in Kidney Diseases. Ladan Mehran, M.D., Ph.D., from the Shahid Beheshti University of Medical Sciences in Tehran, Iran, and colleagues examined the association between the trajectory of cMetS-S and development of…
Read More » -
GIPR signaling opens brain’s gate for GLP-1 weight-loss therapy
In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: A new study uncovers how GIPR signaling in brain cells helps GLP-1 weight-loss drugs bypass the blood-brain barrier and amplify their appetite-suppressing effects, offering a mechanistic explanation for the clinical power of co-agonists. Study: Glucose-dependent insulinotropic…
Read More » -
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis – PR Newswire
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR Newswire Novo Nordisk’s obesity drug Wegovy cleared to treat MASH statnews.com Novo Nordisk’s Wegovy Gets US Approval for Liver Disease Bloomberg.com Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH Yahoo Finance Novo Nordisk’s Wegovy gets accelerated US approval for liver…
Read More » -
Mounjaro weight-loss drug price to almost triple in UK after Trump complaint
The price of popular weight-loss jab Mounjaro will nearly triple after the US-owned company equalised costs in markets across the globe. A month’s supply of the highest doses of the “King Kong” of weight loss medicine will rise from £122 to £330 – an increase of 170 per cent. At least 500,000 people in the UK take either Mounjaro or…
Read More »
